PLSD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't have very many shares though...
PSTG has been good to me!
I made money here at the beginning of 2021 but three years later nothing, No reason to sell.
I've been holding QBTS for more than half a year; I plan to wait for that $2.
RG** is helping me in the industry while we are down here today!
Good luck out there!
Wow, you're still here. Man, I'm still holding shares here too.
You have way more hope than me on HESG, but I wish you well!
Let's get that $2 bill!
Hoping for the best on Thursday!
D-Wave Quantum Inc. Announces Date for Third Quarter 2023 Earnings Call
PALO ALTO, Calif. & BURNABY, British Columbia--(BUSINESS WIRE)-- D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software, and services, today announced it will release its financial results for the third quarter ended September 30, 2023 on Thursday, November 9 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavesys.com/.
In conjunction with this announcement, D-Wave will host a conference call on Thursday, November 9, 2023, at 8:00 a.m. (Eastern Time), to discuss the Company’s financial results and business outlook. The live dial-in number is 1-800-908-9179 (domestic) or 1-312-281-1211 (international). Participating in the call will be Chief Executive Officer Alan Baratz and Chief Financial Officer John Markovich.
About D-Wave Quantum Inc.
D-Wave is a leader in the development and delivery of quantum computing systems, software, and services, and is the world’s first commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. Our mission is to unlock the power of quantum computing today to benefit business and society. We do this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory.
Forward-Looking Statements
Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this press release include, but are not limited to, statements regarding the timing of the company’s release of financial results and the associated conference call. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; our ability to expand our customer base and the customer adoption of our solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.
https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231025931450r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231025931450/en/
Investor Contact:
Kevin Hunt
ir@dwavesys.com
Media Contact:
Alex Daigle
media@dwavesys.com
Source: D-Wave Quantum Inc.
Over 72% of shares held by institutional investors.
https://www.nasdaq.com/market-activity/stocks/qbts/institutional-holdings
8K filed 10/24/2023.
"Under the NYSE’s rules, if the Company determines that, if necessary, it will cure the stock price deficiency by taking an action that will require stockholder approval, it must so inform the NYSE in the above referenced notification and the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price remains above that level for at least the following 30 trading days. The Company intends to consider available alternatives, including but not limited to a reverse stock split, that are subject to shareholder approval."
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=317816838&type=PDF&symbol=QBTS&cdn=93e4114dee04badcb3a4b486e097dad7&companyName=D-Wave+Quantum+Inc.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2023-10-24
Yes, I'm not a fan of reverse splits either. When do you suspect they would execute one?
I agree with your sentiment.
I'm holding my quantum computing stocks for the long-term, though it hurts to see this sell-off with insiders leading the way.
Seems they're doing a good job at it.
I don't want to see QBTS get delisted from the NASDAQ. Guess others out there; want exactly that outcome.
Lets get that $1 bill!
It took me a while to remember about GW Pharmaceuticals. They were one of the realest companies around pertaining to medical cannabis from the UK. I first heard about GW in 2008 when I began investing in the cannabis industry, I should have invested there but I was focusing on USA companies.
Thanks for the insight. I'm holding, but not sure if I want to add more and at what price.
Couple of years ago I purchased about 500 shares of MNMD. It's price has travelled down ever since then.
Went through two corporate restructures; for which I was charged a prompt $38 each. Not cool.
Anyways, currently have 33 shares after the last reverse split. One of the more ugly ones.
Post split it's price started at $12 and it's now $3.41 as of close Friday.
Currently, I'm holding to see what happens because I have faith in the industry for medicine.
Managment needs to focus on LSD since it's been 80 years since it's discovery by Albert Hofmann in Basel, Switzerland providing troves of data.
It is the most researched psychedelic and non-toxic. Remember, Hofmann also was first to synthesize Psilocybin and lived to be 102.
Never took too big of a position in NUGS. I was bullish in the past...
Reasons for doing so:
Compared to other microcaps, this one had a relatively small float
CA is a state with legal cannabis laws
Seemed it was working with OTC Markets to move up the tiers
Federal legalization without delayed could have increased share price
Now:
Float increased a lot
Federal legalization is the can getting kicked down the road
Company said there is a serious doubt they have a Going Concern
Holding only 5,000 shares, so it's a small loss to date.
Good Luck to others out there!
I am not happy with it either.
The float went up substantially and the Going Concern section tells it all.
NOTE 3 – GOING CONCERN
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $59.8 million at March 31, 2022, and net loss of $8,596,634 for the year ended March 31, 2022. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern.
While the Company is attempting to commence operations and generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of a public or private offering. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to
generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues.
The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
07/15/2022 Annual Report - Annual Report
Trading symbol: NUGS
Exact title and class of securities outstanding: Common
CUSIP: 13765M109
Par or stated value: $0.001
Total shares authorized: 988,000,000 as of date: March 31, 2022
Total shares outstanding: 366,817,287 as of date: March 31, 2022
Number of shares in the Public Float 6: 165,163,340 as of date: March 31, 2022
Total number of shareholders of record: 173 as of date: March 31, 202
https://www.otcmarkets.com/stock/NUGS/disclosure
SUPPLEMENTAL INFORMATION AND DISCLOSURE STATEMENT
Period Ending June 14th, 2022
Cannabis Strategic Ventures, Inc.
CUSIP: 13765M109
Trading Symbol: NUGS
On June 10th, 2022, the Board of Directors of the Company entered into a binding Stock Purchase Agreement with a private party (“Buyer”) to sell the Company’s Downtown Los Angeles Cannabis licenses.
In the terms of the agreement, the Company is selling its interest in their Downtown Los Angeles Cannabis permits and licenses consisting of a Store Front Retailer, Distributor, Manufacture and Medium Indoor Cultivation licenses to the Buyer for $3,800,000.
The Company plans to use the proceeds of the sale for operational expenses, capital expenditures and growth capital for its 6-acre cannabis cultivation in Northern California.
At the time of this notice, all parties have signed the binding Stock Purchase Agreement but closing deliverables are still in the process of being completed.
By: /s/Pyng Soon
Director
https://www.otcmarkets.com/stock/NUGS/disclosure
Where's the year end financials? Any news?
Come on Cannabis Strategic Ventures; don't squander the NUGS!
Low float on this one.
Total shares authorized: 988,000,000 as of date: December 31, 2021
Total shares outstanding: 287,300,141 as of date: December 31, 2021
Number of shares in the Public Float6: 90,327,895 as of date: December 31, 2021
Total number of shareholders of record: 174 as of date: December 31, 2021
02/22/2022 Quarterly Report - Quarterly Report 12/31/2021
https://www.otcmarkets.com/stock/NUGS/disclosure
Came here when HESG was supposed to get into Cannabis in 2009.
Never left. It is what it is!
Well, looking from the outside it looks bleak.
The Florida reinstatement was rejected.
However, the domain name for HESG has been updated two days ago.
The only hope at this junction is that the connections to INAR and EXMT was/is legit because this ticker is doomed otherwise.
Sorry, I forgot the new phrasing. Yes, you're right.
What is the Expert Market?
https://blog.otcmarkets.com/2021/03/25/understanding-the-expert-market/
Can't tell if you're kidding, but I'll take the Expert Market.
Average for me is at $0.00013 so HESG right now is sort of fun.
I realize HESG is on death row. I would love to see $0.0025!!
HESG's otcmarkets.com website domain updated yesterday.
Expired on Sunday the 8th. Still shows Conduct Science on Whois.
The HESG site listed on otcmarkets.com expired yesterday?
Maybe that site was preventing the update in FL?
http://www.hesciencesgroup.com/
https://www.otcmarkets.com/stock/HESG/profile
Anyone figure out the connection to Conduct Science?
The Whois site still has them as the website.
https://whois.domaintools.com/hesciencesgroup.com
https://conductscience.com/human-lab/digital-health/
To see HESG legit after 10 plus years would be a wonder.
Happy you're still around here...
What's the chance HESG comes from behind in crunch time?
No matter what happens here I already got mine! Go HESG!!
While watching the news on the reinstatement, I'll be checking on this Whois Record for HeSciencesGroup.com status.
354 days old
Created on 2020-08-08
Expires on 2021-08-08
The August date is obviously before the SEC September dates!
I'm doing well thanks.
Yesterday was a bit lackluster, though this month is inherently interesting due to SEC Rule 15c2-11.
Hoping HESG is legit by the end of the month.
You weren't kidding... Hold those shares!
According to Google:
"Volume precedes Price" is a Wall Street adage that's particularly relevant if one studies volume in big transactions, for example, in trading of large blocks of stock (typically, 10,000 shares or more).
GO HESG
I agree. Would like to see otcmarkets.com updates as well!
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20210602|HESG|651756756|0|876030387|O
http://regsho.finra.org/FORFshvol20210602.txt
74.3% of June 2, 2021 HESG volume showed up on the short file.
651 million shares.
Interesting...
Ears perked!
Filing Information
Document Number
P09000012683
FEI/EIN Number
N/A
Date Filed
02/09/2009
State
FL
Status
INACTIVE
Last Event
PENDING REINSTATEMENT
Event Date Filed
06/02/2021
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=HEALTHSCIENCESGROUP%20P090000126830&aggregateId=domp-p09000012683-075e16c5-6b4f-47c1-8417-4e9af617210f&searchTerm=health%20sciences%20group&listNameOrder=HEALTHSCIENCESGROUP%20P090000126830
Buy in at $0.12, NUGS awaiting filings.